A
Description
Pre-clinical stage UK biotech company (founded 2019), spin-out from Trinity College Dublin. Develops novel treatments for autoimmune diseases based on a naturally occurring micronutrient called queuine, which controls autoimmune response through the tRNA guanine transglycosylase (TGT) enzyme pathway. Focus areas: rheumatoid arthritis and multiple sclerosis.